Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Intervention Indication Therapeutic Area Year Actions
Atezolizumab for previously untreated recurrent or advanced non-small cell lung cancer unsuitable for platinum-doublet chemotherapy Atezolizumab (Tecentriq; MPDL3280A) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Atezolizumab for muscle-invasive urothelial carcinoma –adjuvant Atezolizumab (Tecentriq; MPDL3280A) Bladder cancer Urological Cancer 2019 View  |  Download
Atezolizumab for adjuvant treatment of squamous cell carcinoma of the head and neck Atezolizumab (Tecentriq; MPDL3280A) Head and neck cancer Head and Neck Cancer 2021 View  |  Download
Atezolizumab adjuvant therapy for treating renal cell carcinoma in people at high risk of developing metastasis following nephrectomy Atezolizumab (Tecentriq; MPDL3280A) Renal cell carcinoma (RCC) Renal Cancer 2022 View  |  Download
Atezolizumab (Tecentriq) and Cobimetinib (Cotellic) for advanced/metastatic colorectal cancer - third line Atezolizumab (Tecentriq; MPDL3280A) , Cobimetinib (Cotellic; GDC-0973; cobimetinib hemifumarate) Colorectal cancer Gastrointestinal Cancer , Oncology 2017 View  |  Download
ATB200/AT2221 for Late onset Pompe disease in adults and adolescents over 12 years – first line ATB200/AT2221 Pompe disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2020 View  |  Download
Ataluren for Duchenne Muscular Dystrophy with nonsense mutation Ataluren (Translarna; PTC 124; PTC-124; PTC124) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2022 View  |  Download
AT406 (Debio 1143) for Ovarian Cancer – neoadjuvant therapy Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Xevinapant (Debio 1143; AT-406) Ovarian cancer Female Reproductive Cancer 2018 View  |  Download
ASTX727 for acute myeloid leukaemia ASTX727 Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2022 View  |  Download
Asinercept (Apocept) for glioblastoma multiforme for first or second line Asunercept (Apocept; APG101) Glioma Neurological Cancer 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications